Confirmatory Clinical Study in Active Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT07296315
Confirmatory Clinical Study in Active Ulcerative Colitis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-04-03Est. Completion: 2027-09
Enrollment target: 204 participants Locations- ARA Professionals, Miami, Florida, United States
- Tropical Clinical Trials, Palmetto Bay, Florida, United States
- Cross Creek Medical Clinic, Fayetteville, North Carolina, United States
- Peters Medical Research, High Point, North Carolina, United States
- Southern Star Research Institute, San Antonio, Texas, United States
- K. Eristavi National Center of Experimental and Clinical Surgery JSC, Tbilisi, Georgia
- LTD Krol Medical Corporation, Tbilisi, Georgia
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Recruiting
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that requires regular monitoring of disease activity. Cu…
Asyut, EgyptEst. completion Jan 31, 2027